Acme Universal Safezone 9 IPO
ACMEUNIV · Footwear · BSE
IPO Opportunity Score
63/100
Average Opportunity
Apply?
Selective Apply
Risk
Moderate
Est. listing gain
16–25%
Retail allotment odds
5.6%
HNI allotment odds
9%
Mixed signals — selective apply only if thesis fits your risk appetite. Prefer 1 lot to limit capital blocked. SME IPOs carry higher liquidity and volatility risk.
Retail and HNI allotment odds are illustrative (often using total subscription as a proxy when category-wise data is unavailable).
Price band
₹65 – ₹71
GMP
+₹16 (+22.54%)
Est. listing
₹87
Issue size
₹36 Cr
Subscription
17.8x
Min. investment
₹2,27,200
GMP last updated: 6-Oct 9:37
IPO DNA
A multi-dimensional read instead of a single number. 3 of 8 dimensions can be assessed from the data we receive — the rest are shown as gaps rather than filled with placeholder scores.
Relative strengths
Demand, Listing Setup
Relative weaknesses
Liquidity
Business Quality
No dataCompany financials (revenue, profit, ROE/ROCE, debt) are not part of the IPO feed we consume.
Growth
No dataCompany financials (revenue, profit, ROE/ROCE, debt) are not part of the IPO feed we consume.
Financial Strength
No dataCompany financials (revenue, profit, ROE/ROCE, debt) are not part of the IPO feed we consume.
Valuation
No dataValuation multiples and peer comparables are not available from our current data sources.
Demand
70/100Total subscription of 17.81x across all categories. Category-wise (QIB/NII/Retail) split is not published in our feed, so this is overall demand only.
Listing Setup
75/100Derived from an unofficial grey-market premium of 22.54%. Last updated 6-Oct 9:37. GMP is unregulated and can reverse quickly.
Governance
No dataPromoter holding, pledge and anchor-investor data are not available from our current data sources.
Liquidity
35/100Structural read from a ₹36 Cr issue. SME platform listings typically trade in thinner volumes than mainboard. This reflects issue structure, not observed post-listing volume.
Dimensions are analytical views built from published issue data and unofficial grey-market quotes. They are not a recommendation to apply for or avoid this IPO.
GMP Divergence Check
Cross-checks the unofficial grey-market premium against visible demand and issue structure, so a strong premium is not read in isolation.
No divergence detected
Premium and demand are broadly consistent
Checks we could not run
- Valuation vs peers — multiples and comparables are not in our data sources.
- Institutional (QIB) demand quality — category-wise subscription is not published in our feed.
- Anchor-investor participation — not available from our data sources.
Grey-market premium is unofficial and unregulated. This check describes signal consistency only and is not investment advice.
Information Confidence
How complete and fresh the information behind this page is — kept separate from any view on the IPO itself, so a well-documented issue is never confused with an attractive one.
Grey-market premium last updated 6-Oct 9:37.
Published (10)
Price band · Lot size · Issue size · Bidding dates · Listing date · Allotment date · Registrar details · RHP document · Company profile · Subscription figures
Awaiting disclosure (0)
Every expected field is available for this issue.
Not collected by this site
- Company financials — revenue, profit, ROE/ROCE, debt
- Valuation multiples and peer comparables
- Category-wise subscription (QIB / NII / Retail / Employee)
- Anchor investors and promoter holding
- Fresh issue vs offer-for-sale split
Sources
- officialExchange / issuer feed (price band, dates, lot size, documents)
- unofficialGrey-market aggregator (premium only)
Scenario Lab
Test this issue against your own assumptions. Every output here is a scenario you control, not a forecast of what will happen.
Break-even price
₹72
1.01% above issue price
Capital deployed
₹1,13,600
1600 shares
Costs recovered
₹1,142
Both legs of the trade
Tax assumption
20%
Applied to gains above break-even
Cost and tax inputs are yours to set — we do not apply a default brokerage plan or assume your tax slab. Confirm actual charges with your broker and tax treatment with a qualified professional. Scenarios are illustrative and not predictions.
About the company
Issue details
Timeline
Registrar
MAASHITLA SECURITIES PRIVATE LIMITED
Contact: Mukul Agrawal
Phone: +91 011 4758 1432
investor.ipo@maashitla.comVisit registrar website →Documents
IPO data from Upstox; GMP from unofficial grey-market aggregators. GMP is not regulated and does not guarantee listing performance. Scorecard uses GMP + subscription heuristics — not investment advice.
About Acme Universal Safezone 9 IPO IPO
IPO detail with price band, GMP, scorecard, subscription heat, timeline and registrar links.
How it works
Review the opportunity score and documents (RHP/DRHP), then use allotment or GMP calculators.
Practical tips
Note allotment and listing dates on your calendar before you apply.
Important to know
GMP and scores are informational — not apply advice.
Related tools
Frequently Asked Questions
- What details are shown for Acme Universal Safezone 9 IPO?
- Company summary, price band, timeline, lot size, and grey-market premium (GMP) when the data source provides them.
- What is GMP and should I trust it?
- GMP is an unofficial grey-market indication of listing sentiment. It can reverse quickly and is not a guarantee of listing gains.
- Can I apply for the IPO on EnrichReturns?
- No. Apply via ASBA through your bank or broker UPI flow as per the exchange process.
- Where should I read official risk disclosures?
- Always read the Red Herring Prospectus (RHP) and exchange filings. This page is informational, not investment advice.
- How fresh is subscription and GMP data?
- Figures depend on upstream feeds and may lag. Confirm live subscription on NSE/BSE and treat GMP as speculative.
- Is SME different from mainboard?
- Yes. SME IPOs have different lot sizes, eligibility, and liquidity profiles. Check the issue type before applying.